Eli Lilly and Co. (NYSE:LLY) on Monday shared positive topline results from the Phase 3 LIBRETTO-432 clinical trial for ...

As is often the case with cancer treatments, many patients are able to benefit from therapy for a time. Tumor activity ...

Optune Pax® with the chemotherapy combination of gemcitabine and nab-paclitaxel is the first treatment to be FDA approved in nearly 30 years for locally advanced pancreatic cancer.

Some six years after the FDA approved Eli Lilly’s Retevmo to treat lung a | Six years after the FDA approved Eli Lilly’s ...

Soon-Shiong said that ImmunityBio has also initiated the process of establishing a “world bank of natural killer cells.

In 2026, an estimated 67,530 people will be diagnosed with pancreatic cancer, according to the American Cancer Society. But imagine a treatment that could completely eliminate pancreatic cancer tumors ...

Better short-term survival with apalutamide versus darolutamide, but lots of unanswered qu ...

Nearly 70% of cancer drugs granted FDA accelerated approval between 2011 and 2020 required safety updates within 4 years.“Postmarketing safety actions are common,” Maryam Mooghali, MD, MSc, internal ...

Resistant cells demonstrated global decreases in DNA accessibility with localized opening at resistance-driving loci, indicating non-mutational epigenetic reprogramming rather than canonical oncogenic ...

By Pushkala Aripaka, Bhanvi Satija and Maggie Fick LONDON, Feb 10 (Reuters) - AstraZeneca forecast steady profit growth in ...

A blood test for detecting cancer early being developed by the diagnostics firm Grail failed to meet its main goal in a giant ...